What is the current stock price of AVITA Medical, Inc. (RCEL)?

As of the latest market data, AVITA Medical, Inc. (RCEL) is trading at $5.01. The stock has seen a gain of 10.35% today.

Does AVITA Medical, Inc. (RCEL) pay a dividend?

Based on current data, AVITA Medical, Inc. does not have a confirmed active dividend policy.

What is the market cap of AVITA Medical, Inc.?

The current market capitalization of AVITA Medical, Inc. (RCEL) is approximately unavailable.

RCEL

AVITA Medical, Inc.·Healthcare

5.01

10.352%(+0.47)

Market Closed

5.30

5.788%(+0.29)

After Hours

Last Updated: — ET

52W L: $3.2252W H: $10.29

RCEL NEWS

globenewswire.com

3d ago

AVITA Medical Showcases Acute Burn and Wound Care Portfolio at ABA 2026, Featuring New Cohealyx Data

AVITA Medical highlights new Cohealyx data and real-world evidence at upcoming ABA 2026, advancing wound healing and improving patient recovery outcomes

defenseworld.net

Mar 22

Avita Medical Inc. (NASDAQ:RCEL) Receives Consensus Recommendation of “Hold” from Analysts

Avita Medical Inc. (NASDAQ: RCEL - Get Free Report) has earned an average rating of "Hold" from the six ratings firms that are currently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and two have issued a buy recommendation on the

zacks.com

Feb 25

Wall Street Analysts Believe Avita Medical (RCEL) Could Rally 29.87%: Here's is How to Trade

The consensus price target hints at a 29.9% upside potential for Avita Medical (RCEL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

globenewswire.com

Feb 23

AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference

VALENCIA, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced Cary Vance, Interim CEO, and David O'Toole, CFO, will be participating in the upcoming TD Cowen 46th Annual Health Care Conference in Boston, MA.

zacks.com

Feb 19

Avita Medical (RCEL) Upgraded to Buy: Here's What You Should Know

Avita Medical (RCEL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

seekingalpha.com

Feb 19

AVITA Medical, Inc. (RCEL) Discusses Financial Performance, Sales Strategy, and Reimbursement Progress Transcript

Company Profile

AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and a research collaboration with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. was incorporated in 2000 and is based in Valencia, California.

Sector

Healthcare

Industry

Medical - Devices

Employees

260

IPO Date

2012-05-14

Beta

1.89

Websitewww.avitamedical.com↗